{"transactions":[{"id":1717541,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":96295,"kind":"person","name":"Callaway James Eric","position":1,"cik":"0001715787","reported_name":"Callaway James Eric","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2023-12-08T22:30:15.000Z","date":"2023-12-06","kind":"grant","planned":false,"acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest 100% on the twelve-month anniversary of the grant date."}],"balance_after":2500,"derivative":{"exercise_price":4.29,"expiration_date":"2033-12-06","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001683168-23-008739","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534525/000168316823008739/ownership.xml","form_type":"4"}},{"id":2090826,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":96295,"kind":"person","name":"Callaway James Eric","position":1,"cik":"0001715787","reported_name":"Callaway James Eric","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-12-09T22:02:18.000Z","date":"2022-12-07","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest 100% on the twelve-month anniversary of the grant date."}],"balance_after":25000,"derivative":{"exercise_price":0.4367,"expiration_date":"2032-12-07","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001683168-22-008321","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534525/000168316822008321/ownership.xml","form_type":"4"}},{"id":2478597,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":96295,"kind":"person","name":"Callaway James Eric","position":1,"cik":"0001715787","reported_name":"Callaway James Eric","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2021-12-09T22:39:36.000Z","date":"2021-12-07","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest 100% on the twelve-month anniversary of the grant date."}],"balance_after":25000,"derivative":{"exercise_price":1.44,"expiration_date":"2031-12-07","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001683168-21-006228","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534525/000168316821006228/ownership.xml","form_type":"4"}},{"id":2953053,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":96295,"kind":"person","name":"Callaway James Eric","position":1,"cik":"0001715787","reported_name":"Callaway James Eric","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2020-12-08T22:00:57.000Z","date":"2020-12-04","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest 100% on the twelve-month anniversary of the grant date."}],"balance_after":25000,"derivative":{"exercise_price":1.1,"expiration_date":"2030-12-04","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001683168-20-004203","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534525/000168316820004203/ownership.xml","form_type":"4"}},{"id":3349369,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":96295,"kind":"person","name":"Callaway James Eric","position":1,"cik":"0001715787","reported_name":"Callaway James Eric","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2019-12-06T23:25:29.000Z","date":"2019-12-04","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest 100% on the twelve-month anniversary of the grant date."}],"balance_after":25000,"derivative":{"exercise_price":1.31,"expiration_date":"2029-12-04","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001683168-19-003911","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534525/000168316819003911/ownership.xml","form_type":"4"}},{"id":3747231,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":96295,"kind":"person","name":"Callaway James Eric","position":1,"cik":"0001715787","reported_name":"Callaway James Eric","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2018-11-30T22:24:59.000Z","date":"2018-11-28","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest in equal quarterly installments over the twelve-month period commencing on the grant date."}],"balance_after":25000,"derivative":{"exercise_price":3.05,"expiration_date":"2028-11-28","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001662252-18-000107","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534525/000166225218000107/ownership.xml","form_type":"4"}},{"id":4186413,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":96295,"kind":"person","name":"Callaway James Eric","position":1,"cik":"0001715787","reported_name":"Callaway James Eric","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2017-10-13T20:54:11.000Z","date":"2017-10-11","kind":"grant","acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 11, 2017 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its 2014 Equity Incentive Plan (the \"Plan\"). The Reporting Owner has the right to purchase 25,000 shares of common stock of the Issuer under the Plan at an exercise price based on the closing price on October 11, 2017 of $2.95. The Option vests one-quarter of the total grant for each quarter of service over the twelve-month period commencing on the grant date."}],"balance_after":25000,"derivative":{"exercise_price":2.95,"exercise_date":"2018-10-11","expiration_date":"2027-10-11","underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001662252-17-000207","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1534525/000166225217000207/form4.xml","form_type":"4"}},{"id":4186412,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":96295,"kind":"person","name":"Callaway James Eric","position":1,"cik":"0001715787","reported_name":"Callaway James Eric","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2017-10-13T20:54:11.000Z","date":"2017-10-11","kind":"grant","acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 11, 2017 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its 2014 Equity Incentive Plan (the \"Plan\"). The Reporting Owner has the right to purchase 25,000 shares of common stock of the Issuer under the Plan at an exercise price based on the closing price on October 11, 2017 of $2.95. The Option vests one-quarter of the total grant for each quarter of service over the twelve-month period commencing on the grant date."}],"balance_after":18750,"derivative":{"exercise_price":2.95,"exercise_date":"2018-07-11","expiration_date":"2027-10-11","underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001662252-17-000207","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1534525/000166225217000207/form4.xml","form_type":"4"}},{"id":4186411,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":96295,"kind":"person","name":"Callaway James Eric","position":1,"cik":"0001715787","reported_name":"Callaway James Eric","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2017-10-13T20:54:11.000Z","date":"2017-10-11","kind":"grant","acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 11, 2017 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its 2014 Equity Incentive Plan (the \"Plan\"). The Reporting Owner has the right to purchase 25,000 shares of common stock of the Issuer under the Plan at an exercise price based on the closing price on October 11, 2017 of $2.95. The Option vests one-quarter of the total grant for each quarter of service over the twelve-month period commencing on the grant date."}],"balance_after":12500,"derivative":{"exercise_price":2.95,"exercise_date":"2018-04-11","expiration_date":"2027-10-11","underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001662252-17-000207","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1534525/000166225217000207/form4.xml","form_type":"4"}},{"id":4186410,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":96295,"kind":"person","name":"Callaway James Eric","position":1,"cik":"0001715787","reported_name":"Callaway James Eric","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2017-10-13T20:54:11.000Z","date":"2017-10-11","kind":"grant","acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 11, 2017 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its 2014 Equity Incentive Plan (the \"Plan\"). The Reporting Owner has the right to purchase 25,000 shares of common stock of the Issuer under the Plan at an exercise price based on the closing price on October 11, 2017 of $2.95. The Option vests one-quarter of the total grant for each quarter of service over the twelve-month period commencing on the grant date."}],"balance_after":6250,"derivative":{"exercise_price":2.95,"exercise_date":"2018-01-11","expiration_date":"2027-10-11","underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001662252-17-000207","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534525/000166225217000207/form4.xml","form_type":"4"}}]}